-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EmYTVdcr3eY7SiYEEb4LQ+w0cxX++WBlGuYTucdsgzRnOG2gT176f9QDAupEfFqi zzgtPySqvVTF47zIpmQq8A== 9999999997-06-041104.txt : 20061004 9999999997-06-041104.hdr.sgml : 20061004 20061004091953 ACCESSION NUMBER: 9999999997-06-041104 CONFORMED SUBMISSION TYPE: REGDEX/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: FILED AS OF DATE: 20060612 DATE AS OF CHANGE: 20061004 EFFECTIVENESS DATE: 20060612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RA Capital Biotech Fund LP CENTRAL INDEX KEY: 0001315082 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: REGDEX/A SEC ACT: 1934 Act SEC FILE NUMBER: 021-74043 FILM NUMBER: 06025051 BUSINESS ADDRESS: STREET 1: 111 HUNTINGTON AVE CITY: BOSTON STATE: MA ZIP: 02199 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVE CITY: BOSTON STATE: MA ZIP: 02199 REGDEX/A 1 9999999997-06-041104.paper AUTO-GENERATED PAPER DOCUMENT This document was generated as part of a paper submission. Please reference the Document Control Number 06025051 for access to the original document. -----END PRIVACY-ENHANCED MESSAGE-----